3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
19
Myeloproliferative Disorders
16
Polycythemia Vera
10
Leukemia
8
Leukemia, Myeloid, Acute
7
Breast Neoplasms
6
Pancreatic Neoplasms
5
Myelodysplastic Syndromes
5
Hematologic Diseases
5
Thrombocythemia, Essential
4
Multiple Myeloma
4
Bone Marrow Diseases
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Myelodysplastic-Myeloproliferative Diseases
3
Leukemia, Myelomonocytic, Chronic
3
Graft vs Host Disease
3
Thrombocytosis
2
Prostatic Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Bronchiolitis Obliterans Syndrome
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Preleukemia
1
Precancerous Conditions
1
Pathologic Complete Response
1
Interventions
Mycophenolic Acid
17
fludarabine phosphate
16
Cyclophosphamide
15
Whole-Body Irradiation
10
Tacrolimus
10
Melphalan
10
Peripheral Blood Stem Cell Transplantation
9
Filgrastim
9
Cyclosporine
9
Busulfan
9
Antilymphocyte Serum
8
Granulocyte Colony-Stimulating Factor
7
thymoglobulin
6
Methotrexate
6
Cord Blood Stem Cell Transplantation
5
fludarabine
4
Thiotepa
4
Radiotherapy
4
Methylprednisolone
4
Etoposide
4
Cytarabine
4
Stem Cell Transplantation
3
Rituximab
3
Clofarabine
3
Transplantation
2
Sirolimus
2
Methylprednisolone Hemisuccinate
2
Methylprednisolone Acetate
2
Etanercept
2
Alemtuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myelomonocytic, Juvenile
×
ruxolitinib
×
Clear all
No trials found.